Pericoronary radiomics texture features associated with hypercholesterolemia on a photon-counting-CT.

hypercholesterolemia pericoronary adipose tissue photon-counting computed tomography radiomics texture analysis

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 15 05 2023
accepted: 18 10 2023
medline: 15 11 2023
pubmed: 15 11 2023
entrez: 15 11 2023
Statut: epublish

Résumé

Pericoronary adipose tissue (PCAT) stands in complex bidirectional interaction with the surrounding arteries and is known to be connected to many cardiovascular diseases involving vascular inflammation. PCAT texture may be influenced by other cardiovascular risk factors such as hypercholesterolemia. The recently established photon-counting CT could improve texture analysis and help detect those changes by offering higher spatial resolution and signal-to-noise ratio. In this retrospective, single-center, IRB-approved study, PCAT of the left and right coronary artery was manually segmented and radiomic features were extracted using pyradiomics. The study population consisted of a test collective and a validation collective. The collectives were each divided into two groups defined by the presence or absence of hypercholesterolemia, taken from self-reported conditions and confirmed by medical records. Mean and standard deviation were calculated with Pearson correlation coefficient for correlation of features and visualized as boxplots and heatmaps using R statistics. Random forest feature selection was performed to identify differentiating features between the two groups. 66 patients were enrolled in this study (34 female, mean age 58 years). Two radiomics features allowing differentiation between PCAT texture of the groups were identified ( Texture analysis of PCAT allowed differentiation between patients with and without hypercholesterolemia offering a potential imaging biomarker for this specific cardiovascular risk factor.

Identifiants

pubmed: 37965085
doi: 10.3389/fcvm.2023.1223035
pmc: PMC10642353
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1223035

Informations de copyright

© 2023 Kahmann, Tharmaseelan, Riffel, Overhoff, Papavassiliu, Schoenberg, Froelich and Ayx.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor JL declared a past co-authorship with the author MF.

Références

Br J Pharmacol. 2017 Oct;174(20):3496-3513
pubmed: 28063251
Atherosclerosis. 2016 Aug;251:47-54
pubmed: 27266821
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
J Physiol Pharmacol. 2006 Dec;57(4):505-28
pubmed: 17229978
J Physiol Pharmacol. 2007 Dec;58(4):591-610
pubmed: 18195475
Nat Rev Cardiol. 2019 Feb;16(2):83-99
pubmed: 30287946
Eur Radiol. 2022 Feb;32(2):1256-1266
pubmed: 34435205
Eur Radiol Exp. 2018 Nov 14;2(1):36
pubmed: 30426318
N Engl J Med. 2022 Apr 28;386(17):1591-1602
pubmed: 35240010
J Am Heart Assoc. 2022 Jan 18;11(2):e022879
pubmed: 35023363
Sci Transl Med. 2017 Jul 12;9(398):
pubmed: 28701474
Eur Heart J. 2019 Nov 14;40(43):3529-3543
pubmed: 31504423
Radiology. 2018 Nov;289(2):293-312
pubmed: 30179101
Quant Imaging Med Surg. 2022 Jun;12(6):3436-3453
pubmed: 35655815
Radiology. 2019 Dec;293(3):583-591
pubmed: 31573400
Sci Rep. 2022 Nov 15;12(1):19594
pubmed: 36379992
Diagnostics (Basel). 2022 Jul 08;12(7):
pubmed: 35885567
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Front Cardiovasc Med. 2020 Nov 02;7:591368
pubmed: 33240940
JACC Cardiovasc Imaging. 2020 Nov;13(11):2371-2383
pubmed: 32861654
J Inflamm Res. 2021 Oct 20;14:5419-5431
pubmed: 34707383
Eur Radiol. 2023 Jul;33(7):4905-4914
pubmed: 36809435
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Circ Res. 2016 Feb 19;118(4):535-46
pubmed: 26892956
Eur J Prev Cardiol. 2017 Apr;24(6):660-670
pubmed: 27872327
Radiology. 2022 Apr;303(1):130-138
pubmed: 34904876

Auteurs

Jannik Kahmann (J)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Hishan Tharmaseelan (H)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Philipp Riffel (P)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Daniel Overhoff (D)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, Bundeswehr Central Hospital Koblenz, Koblenz, Germany.

Theano Papavassiliu (T)

First Department of Medicine-Cardiology, University Medical Centre Mannheim, Heidelberg University, Mannheim, Germany.

Stefan O Schoenberg (SO)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Matthias F Froelich (MF)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Isabelle Ayx (I)

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

Classifications MeSH